Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1 Mark J Krasna, MD, Carolyn E Reed,

Slides:

Advertisements

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Advertisements

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 Antonio L Visbal, MD, Brent.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Preoperative Exercise Vo2 Measurement for Lung Resection Candidates: Results of Cancer and Leukemia Group B Protocol 9238 Gregory M. Loewen, DO, Dorothy.

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical management of airway obstruction in primary tuberculosis in children Konstantinos A Papagiannopoulos, Anthony G Linegar, David G Harris, Gawie.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

The True False Negative Rates of Esophageal and Endobronchial Ultrasound in the Staging of Mediastinal Lymph Nodes in Patients With Non-Small Cell Lung.

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R

The Efficacy of Restaging Endobronchial Ultrasound in Patients With Non-Small Cell Lung Cancer After Preoperative Therapy Basil S. Nasir, MBBCh, Ayesha.

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Superior sulcus (Pancoast) tumor: experience with 105 patients

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen,

Ara Chrissian, MD, David Misselhorn, RRT, Alexander Chen, MD

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Who Do You Say You Are? The Annals of Thoracic Surgery

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography Mohamad A Eloubeidi,

Use of Amiodarone After Major Lung Resection

Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time- trend analysis of the National Cancer Data Base Kathryn E. Engelhardt,

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy Shizuka Kaseda, MD, Teruhiro Aoki, MD, Nanae Hangai,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer

Pulmonary Resection for Lung Cancer in Octogenarians

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy Florian Loehe, MD, Sonja Kobinger, MD, Rudolf A Hatz, MD, Thomas.

Lewis Y antigen expression and postoperative survival in non–small cell lung cancer Fumihiro Tanaka, MD, Ryo Miyahara, MD, Yohsuke Ohtake, MD, Kazuhiro.

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael.

Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma Scott.

An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography,

John E Langenfeld, MD The Annals of Thoracic Surgery

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mert Saynak, MD, Jessica Hubbs, MS, Jiho Nam, MD, Lawrence B

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Mediastinal Paragangliomas: The Mayo Clinic Experience

Phase I/II Trial of Hyperfractionated Radiation and Chemotherapy Followed by Surgery in Stage III Lung Cancer Martin J. Edelman, MD, Mohan Suntharalingam,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Minimally invasive resection of mediastinal parathyroid adenomas

Mark I. Block, MD The Annals of Thoracic Surgery

The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Immunohistochemistry analysis of micrometastasis in pretreatment lymph nodes from patients with esophageal cancer Xiaolong Jiao, MD, Afshin Eslami, MD,

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Mark A. Socinski, MD Journal of Thoracic Oncology

A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer Andreas Granetzny, MD,

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography Michael B Wallace, MD, James Ravenel, MD, Mark I Block,

Presentation transcript:

Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1 Mark J Krasna, MD, Carolyn E Reed, MD, William C Nugent, MD, Jemi Olak, MD, David J Sugarbaker, MD, Mark R Green, MD, Leslie J Kohman, MD The Annals of Thoracic Surgery Volume 68, Issue 1, Pages 201-207 (July 1999) DOI: 10.1016/S0003-4975(99)00227-1

Fig 1 Flow of patients through the staging and onto protocols. The Annals of Thoracic Surgery 1999 68, 201-207DOI: (10.1016/S0003-4975(99)00227-1)

Fig 2 Current NSCLC studies per tumor stage. The Annals of Thoracic Surgery 1999 68, 201-207DOI: (10.1016/S0003-4975(99)00227-1)

Fig 3 Mediastinal lymph node map for NSCLC. Reprinted with the permission of the authors, Mountain and Dresler [10]. The Annals of Thoracic Surgery 1999 68, 201-207DOI: (10.1016/S0003-4975(99)00227-1)